BB
BBIO
-4.1%🟢 Fundamentally supportedBridgeBio Pharma, Inc. Common Stock · Healthcare
$63.04Vol 2.71M · 0.9× normalMkt cap −$0.53BMarket closed — 2026-10-13 session
What happened
Move
-4.1%
Price
$63.04
Volume
2.71M
0.9× normal
Market cap
$12.32B
−$0.53B today
Why it moved
Legal / regulatorymedium confidence
- BridgeBio: Maintaining 'Strong Buy' Additional Encaleret Data ADH1 And Three Expected FDA Reviews — finnhub-news
Possible catalyst: legal / regulatory, 3.2pp below its sector.
Verdict — was the move justified?
🟢 Fundamentally supported
Legal / regulatory — direction and rough magnitude are consistent with the identified fundamental catalyst.
How unusual is this move
σ score
2.2σ
vs own 20d volatility
Percentile
76th
of 1269 daily moves
Avg daily move
±3.2%
own 5y average
vs sector
-3.2%
beyond sector median
What happened after similar moves
178 similar down moves in BBIO’s 5-year history:
After 5 days
-1.2%
43% higher
After 20 days
+2.2%
55% higher
Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.
Fundamental context
V 25G 25P 0H 28Q 30
Insider activity (90d): net selling $4.42M
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for BBIO